Patients: Ninety-one of 2898 consecutive visits to a public teaching hospital emergency department were specifically for severe, uncomplicated hypertension. Results: Of 2898 consecutive medical emergency department visits, there were 142 (4.9%) patient visits specifically for systolic blood pressure (SBP) у220 mm Hg or diastolic blood pressure (DBP) у120 mm Hg. Ninety-one of the 142 patient visits were for severe hypertension in the absence of acute target organ impact or neuroretinopathy. Eighty-nine patients received acute drug therapy. Twenty-nine patients received two drugs, and 15 received three drugs. Sixty-
Introduction
Although a large body of literature and numerous guidelines exist for the acute treatment of malignant hypertension and hypertensive emergencies, there is relatively little data available on the more common clinical problems of severe, uncomplicated hypertension and severe hypertension in the presence of stable hypertensive complications. Severe hypertension is defined by the sixth report of the Joint National Committee on Prevention, Detection, eight patients (75%) received clonidine, and 15 (16.5%) received short-acting nifedipine despite widely published concerns about the safety of this practice. We found a wide variability of blood pressure response to treatment. The average decline in SBP was 50 ± 31 mm Hg and the average decline of DBP was 34 ± 20 mm Hg over 4.2 ± 2.9 h. Forty-two patients (46%) had the SBP reduced to less than 160 mm Hg, and 46 patients (50%) the DBP to less than 100 mm Hg. Long-term management and follow-up were suboptimal. Of 74 patients discharged from the emergency room, 22 patients (30%) returned because of uncontrolled hypertension within an average of 33 ± 28 days, 10 patients with hypertensive complications. Conclusions: Severe hypertension continues to present an important and common problem. Physicians appear to place a strong emphasis on acute lowering of the blood pressure to near-normal levels. Patients are frequently lost to follow-up and have a very high rate of recurrent emergency department visits and hypertensive complications. This study points to a need for detailed, specific practice guidelines and comprehensive disease management protocols for severe, uncomplicated hypertension.
Evaluation and Treatment of High Blood Pressure (JNC VI) as systolic blood pressure (SBP) у180 mm Hg or diastolic blood pressure (DBP) у110 mm Hg. Uncomplicated hypertension refers to the absence of hypertensive neuroretinopathy or signs of acute end-organ dysfunction. 1 Severe hypertension with chronic stable complications occurs in the setting of primary renal parenchymal disease with stable chronic renal insufficiency, chronic congestive heart failure, atherosclerotic coronary artery disease, or chronic cerebral vascular disease. Severe, uncomplicated hypertension and severe hypertension in the presence of stable hypertensive complications are the most common presentations of severe hypertension and are often found in patients with chronic primary hypertension who are undiagnosed, undertreated, or non-compliant with medical therapy.
Severe hypertension is a common clinical problem confronting the practitioner. Although patients with severe hypertension constitute a relatively small proportion (11%) of the estimated 60 million US hypertensive population, their absolute number may be 6-7 million. 1, 2 Patients who receive emergency department treatment for severe hypertension are often medically underserved and have limited access to primary care. [3] [4] [5] Severe, uncomplicated hypertension is occasionally discovered incidentally in an otherwise asymptomatic patient.
The appropriate acute management and shortterm follow-up of patients with severe uncomplicated hypertension is currently a matter of discussion. It has been suggested that it is neither necessary nor desirable in most cases to acutely lower the blood pressure in the absence of neuroretinopathy or compelling target organ damage. 1 On the other hand, many practitioners may be reluctant to allow severe hypertensives to remain for even brief intervals without some form of treatment. There is a general lack of clinical trials in both the acute and chronic management of severe uncomplicated hypertension. Accordingly, in the absence of detailed management guidelines and algorithms supported by data from the appropriate clinical trials, practitioners employ a number of diverse protocols, with quite varied results.
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Objectives
We sought to determine: (1) an estimate of the magnitude of the problem of patients with severe uncontrolled hypertension as a percentage of emergency department visits at a large public teaching hospital, (2) reasons why patients present to the emergency department for care, (3) general trends within our own medical centre for the acute management of severe, uncontrolled hypertension, (4) an estimate of the length of time from emergency department treatment to clinic follow-up of patients receiving emergency treatment, and (5) the effectiveness of emergency room-prescribed antihypertensive therapy as measured by outcome of clinic follow-up blood pressure.
Patients and methods
Study design
This is a cross-sectional chart survey designed to collect descriptive data on patients with severe, uncontrolled hypertension presenting acutely to the emergency department at the University of Miami/Jackson Memorial Medical Center over a consecutive period of 2 months (May/June 1998). We collected descriptive data (demographic, clinical, physical examination, laboratory, drugs used for treatment, time course, results of therapy, and follow-up appointments) from a chart review on patients seen in the emergency department with severe, uncontrolled hypertension.
Study population
Inclusion criteria were a DBP у120 mm Hg or SBP у220 mm Hg by emergency department record. These criteria were deliberately set at a higher level than JNC VI criteria for stage 3 hypertension to minimise the effects of regression to the mean and to assure a population with a severe degree of hypertension. Data were obtained by the investigators from a review of the available hospital records. Demographic data included age, gender, race, and ethnicity.
To determine which patients would be classified as having severe, uncomplicated hypertension, and thus form the focus of this study, we used the following general criteria:
(1) Uncomplicated hypertension. Severe hypertension without evidence of acute target organ dysfunction or neuroretinopathy discovered either incidentally or during a routine visit to the clinic such that the patient was transferred to the emergency department for management of blood pressure, or because of non-emergent symptoms related to hypertension such as headache. (2) Clinical and treatment data included blood pressure on presentation, treatment administered, including drugs, dosages, and time period of treatment, post-treatment blood pressure, follow up and discharge plans, medications on discharge, past/present target organ impact, funduscopic examination data, and basic laboratory data. All blood pressure treatment data were from patients who were treated in the emergency department for the length of their stay. The treating physicians were primarily internal medicine residents under the direct supervision of the emergency department attending physicians. The funduscopic exam data for our pilot review was collected from review of exams performed by the treating physician and recorded in the emergency department chart.
Data analysis and statistical methods
Data were tabulated and descriptive statistics computed using personal computer-compatible software.
Results
Of 2898 medical emergency department visits during the months of May-June 1998, there were 142 (4.9%) patient visits for SBP у220 mm Hg or DBP у120 mm Hg ( Figure 1 ). Of these, 32 (22.5%) patients presented with acute target organ damage. Nine of the 32 had suspected or diagnosed acute cor- onary syndrome, 15 acute pulmonary oedema, five cerebrovascular accident or TIA, two with hypertensive neuroretinopathy, and one with acute deterioration of renal function. Nineteen patients (13.4%) had acute problems capable of producing an acute secondary elevation in blood pressure. Ninety-one (64.1%) of the 142 patient visits were primarily for severe hypertension in the absence of acute target organ impact or malignant hypertension and are the focus of our report. Of the 91 patient visits, 15 patients were admitted to the acute medicine inpatient service to control the blood pressure, two patients left the hospital against medical advice without receiving a course of therapy, and the remaining 74 patients were managed acutely in the emergency department and discharged to be followed up in the ambulatory care clinic.
Patients with uncomplicated hypertension or hypertension with stable complications
The 91 patient visits for severe uncomplicated hypertension or hypertension with stable complications among 87 patients were the focus of this study ( Table 1 ). The age of the patients was 54.3 ± 12.5 years. There were 42 women and 45 men. There were 38 African Americans, 27 Hispanic Americans, 18 Haitian Americans, and four AngloAmericans. The majority of the patients were classified by the emergency department personnel as simply hypertension or hypertension out of control.
Of 91 emergency department evaluations for uncomplicated hypertension or severe hypertension with stable hypertensive complications, 29 patients were asymptomatic and had been noted to be hypertensive on routine blood pressure determination in the out-patient clinic, by private primary care provider, or by home determination. Twenty-one patients complained of headache. Sixteen patients had very vague or atypical complaints referred to the chest that were not associated with acute ECG changes or considered cardiac in nature by the emergency department physician. Seven patients complained of dizziness, four epistaxis, and two blurred vision. At least 57 of the 91 visits (62.6%) were primarily related to non-compliance with prescribed medical therapy. Seventy-one of the patients had a previous episode of hypertension treated in the emergency room. Twenty-three patients had a history of coronary artery disease, 13 congestive heart failure, and 12 previous CVA. Twenty-nine patients were diabetic, 28 smoked cigarettes, 36 had left ventricular hypertrophy by ECG, 17 had serum creatinine Ͼ1.5 mg/dl, and 34 patients had proteinuria by dipstick. Six patients admitted to cocaine abuse and 15 patients consumed alcohol. Five patients were positive for HIV.
For the 91 visits only 18 funduscopic exams were recorded on the emergency department record. The funduscopic exams were performed in the emergency department by the treating physician. Two patients had evidence of haemorrhages and or exudates (grade 3) and 15 were recorded as having no haemorrhages and or exudates. There was no mention of tortuous vessels or arteriolar narrowing.
The emergency department treatment and the time course of the lowering of the blood pressure varied widely among the 91 patients (Table 2) . Eighty-nine of the 91 patients received drug therapy. Twenty-nine patients received two drugs, and 15 received three drugs. Sixty-eight patients were treated with clonidine in total dosages of 0.1-0.6 mg over total treatment periods of 1.5-10.0 h in the emergency room. Fifteen of the 91 patients (16.5%) received short-acting nifedipine in total dosages of 10-20 mg over treatment periods of 1.0-7.0 h in the emergency room. Twelve patients received long-acting nifedipine, eight captopril (6.25-25 mg), four 5-13) . The average rate of decline of the SBP was 16 ± 15 mm Hg/h. The presenting DBP was 128 ± 12 mm Hg which was reduced by treatment to 96 ± 15 mm Hg over the 4.2 ± 2.9 hour treatment period (average rate 11 ± 11 mm Hg/h). The average decline of DBP was 34 ± 20 mm Hg (range: increase of 10 mm Hg to decrease of 114 mm Hg). Forty-two patients (46.2%) had their SBP reduced to less that 160 mm Hg, and 46 patients (50%) the DBP to less than 100 mm Hg.
Clonidine for the acute management of hypertension
Sixty-eight of the 91 uncomplicated hypertensives were treated acutely with oral clonidine. Eighteen were treated with 0.1 mg; 28 with 0.2 mg given over 1-13 hours; 10 with 0.3 mg generally given as 0.1 mg and 0.2 mg divided doses over 2-11 hours; nine with 0.4 mg as 0.2 mg doses over 1-7 hours; two with 0.5 mg over 6-13 hours and one with 0.6 mg over 7 hours.
We noted a wide range of blood pressure response to oral clonidine. The presenting SBP was 210 ± 22 mm Hg (range 164 -276) which was reduced with treatment to 155 ± 21 mm Hg (100-206) over a treatment period of 4.5 ± 2.9 hours (0.5-13). The average overall decline in SBP was 56 ± 30 mm Hg (range: increase 26 mm Hg to decrease of 148 mm Hg) The average rate of decline of the SBP was 20 ± 20 mm Hg/h (range: increase of 2 mm Hg/h to decrease of 180 mm Hg/h). The presenting DBP was 129 ± 12 mm Hg which was reduced by treatment to 95 ± 16 mm Hg over the 4.5 ± 2.9 hour treatment period. The average overall decline in DBP was 31 ± 19 mm Hg (range: increase 2 mm Hg to decrease of 118 mm Hg). The average rate of decline was 12 ± 13 mm Hg/h (range: +2 mm Hg to a decline of 84 mm Hg/h).
Using oral clonidine, 40/68 patients (59%) had their SBP reduced to 160 mm Hg or less and 43/68 (63%) had their DBP reduced to 100 mm Hg or less.
Short-acting nifedipine for the acute management of hypertension
Fifteen patients received short-acting nifedipine for their hypertension. All of the patients had uncomplicated severe hypertension, either noted incidentally or presenting with mild symptoms related to the blood pressure. The ages ranged from 35-67 years. Twelve were black and three were white. There were eight men and seven women.
We noted a wide variation in the response to short-acting nifedipine. The mean reduction in SBP was 38 ± 38 mm Hg (range: increase in SBP of 40 mm Hg to decrease of SBP of 100 mm Hg) over an average 56 min (range 12-100 min) The mean reduction of DBP was 32 ± 21 mm Hg (range: increase of 10 mm Hg to decrease of 70 mm Hg). Using nifedipine the average rate of reduction of SBP was 42 mm Hg/h (range: increase 50 mm Hg/h to decrease 182 mm Hg/h), and the average rate of reduction of DBP 47 mm Hg/h (range: increase 12 mm Hg/h to decrease 168 mm Hg/h).
One patient treated with short-acting nifedipine had a history of coronary artery disease and had the blood pressure reduced from 198/126 to 128/78 mm Hg over 90 min. One had a previous cerebrovascular accident (CVA). One patient experienced a sudden and persistent fall in the blood pressure from 214/138 to 100/56 mm Hg. Five other patients had reductions to below 140 mm Hg SBP or 90 mm Hg DBP. Five patients had been treated with clonidine in various dosages prior to receiving short-acting nifedipine.
Follow-up and complications
Of 74 patients discharged from the emergency room, 49 (66%) were scheduled for a follow-up appointment. The mean scheduled interval to the first follow-up appointment was 21 ± 15 days (range 7-86 days) Only six patients (12%) had an appointment scheduled within 1 week of the emergency department visit; 18 patients (37%) had an appointment scheduled for 1-2 weeks; 12 patients (24%) had an appointment between 2 and 3 weeks; and 13 patients (27%) were scheduled for more than 3 weeks. Twenty-five patients (34%) were not scheduled for follow-up within the clinic system because they had their own outside providers or were followed in a satellite clinic. Of the 49 patients with scheduled appointments, 24 patients (45%) were seen in the clinic and 25 (55%) did not attend their follow-up appointment.
Of 74 patients discharged from the emergency room, 22 patients (30%) returned to the emergency department because of uncontrolled hypertension within an average of 33 ± 28 days (range 1-107 days). The age of the 22 patients having repeat visits was 53.4 ± 10.2 year (range 35-71 years). Seventeen were black and five were white. There were 11 African Americans, five Hispanic Americans, five Haitian Americans and one Anglo-American. Twelve patients had had a previous emergency room visit related to non-compliance.
Twelve patients returning with uncontrolled hypertension presented with acute uncomplicated hypertension. Ten patients presented with complications: three with hypertensive encephalopathy, three with congestive heart failure, two with cerebrovascular accident, and two with an acute coronary syndrome. The return emergency department visits were distributed evenly between those who attended a follow-up visit and those who did not. Of 24 patients who were seen on follow-up, seven returned to the emergency department with severe, uncontrolled hypertension. Of the 50 patients who did not attend their follow-up clinic appointments or who were not scheduled for follow-up, 15 returned to the emergency department with severe hypertension.
Discussion
Our study suggests that severe, uncontrolled hypertension remains a serious, common problem among the many inner-city patients treated at public teaching hospitals, despite recent advancements in the management of hypertension and prevention of its complications. In our centre we found that uncontrolled severe hypertension continues to be a major problem from both the standpoints of patient morbidity and utilisation of emergency medical care resources. Uncontrolled severe hypertension accounted for 142 (4.9%) of 2898 consecutive medical emergency department visits over 2 months at our institution. There was a high rate of serious hypertensive target organ complications and repeat emergency department visits for uncontrolled hypertension. Most of the emergency department visits were directly related to non-compliance with prescribed medical therapy.
Although there are few detailed practice standards for the acute management and follow-up of patients with severe but uncomplicated hypertension, we noted several practices that warrant special comment:
(1) Rapid lowering of blood pressure in the absence of target organ damage or malignant hypertension. The rates of lowering of blood pressure for patients with uncomplicated hypertension were in excess of the recommendations for true hypertensive emergencies requiring parenteral therapy. Even for documented hypertensive emergencies requiring acute blood pressure reduction, current JNC VI recommendations are for a careful reduction of mean arterial pressure by no more than 25% within minutes to 2 h, then toward 160/100 mm Hg within 2-6 h. Forty-two patients (46.2%) had their SBP reduced to less that 160 mm Hg, and 46 patients (50%) the DBP to less than 100 mm Hg. (2) The use of repeated doses of oral agents lacks the control of drug titration, and exposes the patient to the risks of 'overshoot' hypotension. In our centre, repeated oral 'loading' of clonidine is a common practice. Most of the doses of clonidine were given as repeated doses of 0.1-0.2 mg at 1-2 h intervals. One patient received 0.6 mg over 7 h. Because the peak effect of clonidine is between 1-3 h, 34 the possibility of a delayed peak onset could result in a prolonged hypotensive response. (3) Use of short-acting nifedipine in 16.5% of cases of uncomplicated hypertension despite widely published concerns 1, 22, 31 about the safety of this practice. Several patients had marked reduction of blood pressure, and the overall blood pressure response among the patients was quite variable and unpredictable. The use of short-acting nifedipine is of special concern in a population of patients with risk factors for underlying coronary artery disease and cerebrovascular disease in whom acute lowering of the blood pressure is probably not warranted. (4) Lack of appropriate follow-up contributing to recurrent emergency department visits for uncontrolled hypertension. There appears to be a need for a standardised brief interval to the first follow-up appointment. (5) Absence of funduscopic examination in the majority of patients to help guide appropriate medical management.
There is little debate over the need to treat patients with accelered or malignant hypertension or severe hypertension when signs of acute endorgan dysfunction are present. On the other hand, there is little data from clinical trials to support the practice of acutely lowering the blood pressure of a hypertensive patient who does not have acute hypertensive complications. In the absence of data from clinical trials, it is difficult to accurately weigh the risk of complications from hypertension within the next several hours to days against the risk of serious side effects of therapy. Although many patients with severe, uncomplicated hypertension are diagnosed and treated as hypertensive urgencies, most cases of uncomplicated hypertension may not require immediate control of the blood pressure. 1, [16] [17] [18] [19] [20] [21] It has been suggested that acute lowering of the blood pressure may actually be detrimental. 1, [17] [18] 22 On the other hand, the adverse effects of inadequate long-term therapy (months) of severe hypertension on the development of target organ effects are well documented. 35, 36 Severe hypertension will lead to significant complications over months to years if untreated, and long-term control is required to reduce cardiovascular risk. In our centre, treatment was characterised by aggressive acute emergency department management with rapid blood pressure lowering. Subsequently, follow-up was suboptimal and many patients were lost to followup. There was a high rate of repeat emergency department visits for uncontrolled hypertension. Twenty-two of 74 patients returned within an average 33 days for uncontrolled hypertension. Ten of these patients suffered acute hypertensive complications. On the other hand, the scheduled interval to first follow-up appointment was surprisingly long (mean 21 days) and lacked uniformity (range: 7-86 days). Would a standard follow-up interval for a blood pressure re-check closer to 2-3 days be more appropriate for a population with severe hypertension, non-compliance, and a high rate of target organ complications?
There appears to be a strong emphasis on acute lowering of the blood pressure but relatively little importance placed on the more important issue of follow-up. We need to carefully re-examine the practice of rapid return of blood pressure to normal over minutes to hours, especially in view of a possible detrimental effect. The effort would perhaps be better spent on close short-term follow-up and subsequent meticulous attention to maintaining the patient at consistent, lower levels of blood pressure over time so the long-term benefits of careful blood pressure control may be realised.
Our results may pertain specifically to inner-city patients treated at public teaching hospitals. We acknowledge that some of our data may be centrespecific, but some of these findings may be representative of other public hospitals that care for innercity populations. There appears to be an important lack of a consistent practice for cautious lowering of the blood pressure and for careful patient follow-up. Although no single antihypertensive regimen is suitable for all situations, we found no consistent method for selection of an initial antihypertensive agent(s), timing of intervals for successive dosages, or for appropriate timing of scheduled follow-up in severe hypertensives. We also must reiterate the key contribution of non-compliance with prescribed medical treatment along with inadequate adherence to clinic follow-up visits to the problem of recurrent emergency department visits for uncontrolled hypertension. Clearly the central priorities in this patient population will be of appropriate follow-up, education, and optimal adherence to prescribed therapy.
Our findings point to an important need to develop and test clinical guidelines for the management of severe, uncomplicated hypertension in the emergency department. This would be part of the development of a broader disease management programme that would incorporate intensive education and follow-up of severe hypertensives.
